Malaysia’s private healthcare sector is pushing back against a new mandate requiring the public display of drug prices. Doctors argue this policy was imposed without meaningful consultation and threatens the financial viability of smaller private practices. How might this regulatory shift reshape the dynamics between private practitioners and public health policy in Malaysia? Unpacking this matter is Azrul Mohd Khalib, CEO, Galen Centre for Health & Social Policy.

Image Credit: Shutterstock.com